tranScrip is now part of TMC
a global pharma services company offering end-to-end drug development solutions, from early-phase consulting and clinical development to market access and drug commercialisation.
Together, we can better support you across the full product lifecycle — with broader regulatory, medical and scientific expertise, plus greater access to specialist subject-matter experts and increased capacity for complex programmes.
